Journal article

Use of Imatinib in Patients with Pulmonary Arterial Hypertension Joint Statement of the "Group Pulmonary Hypertension" of the German Society for Pneumology and the "Working Group Pulmonary Hypertension (AG25)" of the German Society of Cardiology (DGK)


Authors listHoeper, M. M.; Opitz, C.; Olschewski, H.; Ulrich, S.; Speich, R.; Behr, J.; Halank, M.; Wilkens, H.; Klose, H.; Lange, T. J.; Gruenig, E.; Seeger, W.; Ewert, R.; Borst, M. M.; Welte, T.; Rosenkranz, S.; Ghofrani, H. Ardeschir

Publication year2014

PagesS151-S154

JournalDeutsche Medizinische Wochenschrift

Volume number139

ISSN0012-0472

eISSN1439-4413

DOI Linkhttps://doi.org/10.1055/s-0034-1387457

PublisherGeorg Thieme Verlag



Citation Styles

Harvard Citation styleHoeper, M., Opitz, C., Olschewski, H., Ulrich, S., Speich, R., Behr, J., et al. (2014) Use of Imatinib in Patients with Pulmonary Arterial Hypertension Joint Statement of the "Group Pulmonary Hypertension" of the German Society for Pneumology and the "Working Group Pulmonary Hypertension (AG25)" of the German Society of Cardiology (DGK), Deutsche Medizinische Wochenschrift, 139, pp. S151-S154. https://doi.org/10.1055/s-0034-1387457

APA Citation styleHoeper, M., Opitz, C., Olschewski, H., Ulrich, S., Speich, R., Behr, J., Halank, M., Wilkens, H., Klose, H., Lange, T., Gruenig, E., Seeger, W., Ewert, R., Borst, M., Welte, T., Rosenkranz, S., & Ghofrani, H. (2014). Use of Imatinib in Patients with Pulmonary Arterial Hypertension Joint Statement of the "Group Pulmonary Hypertension" of the German Society for Pneumology and the "Working Group Pulmonary Hypertension (AG25)" of the German Society of Cardiology (DGK). Deutsche Medizinische Wochenschrift. 139, S151-S154. https://doi.org/10.1055/s-0034-1387457



Keywords


DOUBLE-BLINDMESYLATEREGISTRYSILDENAFIL

Last updated on 2025-21-05 at 18:35